Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Ardelyx: 3 Key Takeaways for Long-Term Investors

Doubling the field reimbursement team targets prior authorization friction, a hurdle that can stall prescriptions even after demand is established.

  • Ardelyx reported $125.5 million in total product revenue, indicating strong commercial performance.
  • Net loss narrowed to $700,000, with gross profit margins exceeding 95%, creating financial leverage.

More from Wednesday 4 November →